Literature DB >> 11776176

[Expression of basic fibroblastic growth factor and microvessel density in endometrial carcinoma].

X Bai1, R Mi.   

Abstract

OBJECTIVE: To investigate the relation of basic fibroblastic growth factor (bFGF) and microvessel density (MVD) with endometrial carcinoma.
METHODS: A total of 66 specimens of endometrial carcinoma were evaluated by immunohistochemical technique with polyclonal antibody against bFGF. The microvessels were highlight by immunohistologically staining to detect factor VIII-related antigen. The area of the deepest myometrial invasion was selected for staining. Ninteen specimens of uterine prolapse were used for control.
RESULTS: Expression of bFGF was significantly correlated with tumor grade (P < 0.01). MVD was positively correlated with age, tumor grade and myometrial invasion (P < 0.01, respectively). MVD was significantly correlated with expression of bFGF (P < 0.01). Patients with bFGF strong expression and high MVD (> or = 9.4) had worse prognosis (P < 0.01, respectively).
CONCLUSIONS: bFGF plays important role in angiogenesis in endometrial carcinoma. Expression of bFGF and MVD could be used as prognostic factors for survival in endometrial carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11776176

Source DB:  PubMed          Journal:  Zhonghua Fu Chan Ke Za Zhi        ISSN: 0529-567X


  1 in total

1.  A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.

Authors:  D Scott McMeekin; Michael W Sill; Doris Benbrook; Kathleen M Darcy; Deborah J Stearns-Kurosawa; Lynne Eaton; S Diane Yamada
Journal:  Gynecol Oncol       Date:  2007-02-15       Impact factor: 5.482

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.